AgeChem Venture Fund
North America, Quebec, Canada, Montréal
Description
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting
Investor Profile
AgeChem Venture Fund has backed more than 11 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 18% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Series B (45%)
- Series C (18%)
- Series A (18%)
- Series D (9%)
- Series Unknown (9%)
Country Focus
- United States (91%)
- Canada (9%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Biopharma
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
